Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine and nano-silver fluoride mouthwashes in orthodontic patients
IRCT20210620051635N1Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jun 2021
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of chlorhexidine and nanosilver fluoride in carious lesion (3 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Antimicrobial efficacy against oral microorganisms. Started Jun 2021; status: completed.
02
Drugs
chlorhexidinenanosilver fluoride
03
Conditions
carious lesion
Beyond the preview
Go deeper on IRCT20210620051635N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210620051635N1.